ABVC Biopharma Stock

ABVC Biopharma EBIT Margin

The EBIT Margin (Operating Margin) of ABVC Biopharma (ABVC) as of Jul 27, 2026 is -997.16 %. In the previous year, EBIT Margin (Operating Margin) was -908.78 % — a change of 9.73% (lower).

EBIT Margin

-997.16 %

YoY

9.73%

Last updated:

EBIT Margin (Operating Margin) of ABVC Biopharma is 2026 -997.16 % . EBIT Margin (Operating Margin) of ABVC Biopharma was 2025 -908.78 % . It decreases by 9.73% lower compared to the previous year.

ABVC Biopharma's operating (EBIT) margin stands at -997.2%, up from -3,290.1% several years earlier.

Access this data via the Eulerpool API

ABVC Biopharma Stock analysis

What does ABVC Biopharma do? ABVC Biopharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ABVC Biopharma stock

EBIT Margin (Operating Margin) of ABVC Biopharma is -997.16 % in 2026.

Access this data via the Eulerpool API

Margins — ABVC Biopharma

All Key Metrics — ABVC Biopharma